People In Brief
This article was originally published in The Tan Sheet
Executive Summary
J&J names McCoy worldwide pharma head: Sheri McCoy is worldwide chairman of Johnson & Johnson's Pharmaceuticals Group, effective Jan. 1, 2009, filling the opening left by Christine Poon's retirement (1"The Tan Sheet" Sept. 15, 2008, p. 11). The New Brunswick, N.J.-based firm says Alex Gorsky will succeed McCoy as worldwide chairman of its Surgical Care Group, and also join the executive committee. Gorsky is currently the company group chairman and worldwide franchise chairman at J&J franchise Ethicon, Inc. "Sheri and Alex are proven leaders in driving high performance and developing talent across multiple business segments," says J&J CEO Bill Weldon
|
J&J names McCoy worldwide pharma head: Sheri McCoy is worldwide chairman of Johnson & Johnson's Pharmaceuticals Group, effective Jan. 1, 2009, filling the opening left by Christine Poon's retirement (1 (Also see "People In Brief" - Pink Sheet, 15 Sep, 2008.), p. 11). The New Brunswick, N.J.-based firm says Alex Gorsky will succeed McCoy as worldwide chairman of its Surgical Care Group, and also join the executive committee. Gorsky is currently the company group chairman and worldwide franchise chairman at J&J franchise Ethicon, Inc. "Sheri and Alex are proven leaders in driving high performance and developing talent across multiple business segments," says J&J CEO Bill Weldon. NCCAM deputy director: The National Institutes of Health's Center for Complementary and Alternative Medicine names 27-year NIH veteran John "Jack" Killen its deputy director, according to an Oct. 10 release. Killen, who has been with NCCAM since 2003, has served as acting deputy director since August 2007. His earlier NIH career includes seven years at the institutes' extramural clinical trials and investigational drug development program and nearly 15 years at the National Institute of Allergy and Infectious Diseases. He has "extensive leadership experience in creating and managing highly successful multidisciplinary clinical research programs at the NIH," says NCCAM Director Josephine Briggs. Court limits Trudeau in infomercials: Author Kevin Trudeau is banned for three years from infomercials in which he has an interest and ordered to pay more than $5 million in profits from his book, "The Weight Loss Cure 'They' Don't Want You to Know About," according to a ruling that confirms an earlier contempt finding against Trudeau, the Federal Trade Commission announces Oct. 6. The U.S. District Court for the Northern District of Illinois found Trudeau in contempt twice in four years for violating a provision of a 2004 court order prohibiting him from misrepresenting the content of books in his infomercials (2 'The Tan Sheet' Dec. 3, 2007, In Brief). FTC says it first filed suit against Trudeau in 1998, alleging he made false and misleading claims "for products he claimed could cause significant weight loss and cure addictions to heroin, alcohol and cigarettes, and enable users to achieve a photographic memory." |